Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
April 10, 2026
Company name: | OSAKA ORGANIC CHEMICAL INDUSTRY LTD. | ||||
Listing: | Tokyo Stock Exchange | ||||
Securities code: | 4187 | ||||
URL: | https://www.ooc.co.jp/ | ||||
Representative: | Masayuki Ando | Representative Director and CEO | |||
Inquiries: | Soichi Honda | Director, Corporate Officer, General Manager of Administration Division | |||
Telephone: | +81-6-6264-5071 | ||||
Scheduled date to commence dividend payments: | - | ||||
Preparation of supplementary material on financial results: | Yes | ||||
Holding of financial results briefing: | None | ||||
(Yen amounts are rounded down to millions, unless otherwise noted.)
-
Consolidated financial results for the three months ended February 28, 2026 (from December 1, 2025 to February 28, 2026)
-
Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)
Net sales
Operating profit
Ordinary profit
Profit attributable to owners of parent
Three months ended
Millions of yen
%
Millions of yen
%
Millions of yen
%
Millions of yen
%
February 28, 2026
9,072
6.5
1,832
34.2
1,904
28.6
1,285
24.2
February 28, 2025
8,516
20.5
1,365
135.2
1,480
131.3
1,035
71.6
Note: Comprehensive income
For the three months ended February 28, 2026:
¥
3,114 million [
272.9%]
For the three months ended February 28, 2025:
¥
835 million [
(28.3) %]
Basic earnings per share
Diluted earnings per share
Three months ended
Yen
Yen
February 28, 2026
63.22
-
February 28, 2025
49.96
-
- Consolidated financial position
Total assets
Net assets
Equity-to-asset ratio
As of
Millions of yen
Millions of yen
%
February 28, 2026
65,452
52,916
79.4
November 30, 2025
63,713
50,536
78.0
Reference: Equity
As of February 28, 2026:
¥
51,946 million
As of November 30, 2025:
¥
49,700 million
-
Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)
-
Cash dividends
Annual dividends per share
First quarter-end
Second quarter-end
Third quarter-end
Fiscal year-end
Total
Yen
Yen
Yen
Yen
Yen
Fiscal year ended
-
35.00
-
40.00
75.00
November 30, 2025
Fiscal year ending
-
November 30, 2026
Fiscal year ending November 30, 2026
(Forecast)
40.00
-
40.00
80.00
Note: Revisions to the forecast of cash dividends most recently announced: None
Note: Breakdown of the first quarter dividend for the fiscal year ending November 30, 2026 : Commemorative dividend - yen
Special dividend - yen
- Consolidated financial result forecasts for the fiscal year ending November 30, 2026 (from December 1, 2025 to November 30, 2026)
(Percentages indicate year-on-year changes.)
Net sales | Operating profit | Ordinary profit | Profit attributable to owners of parent | Basic earnings per share | |||||
Six months ending May 31, 2026 | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen |
18,200 | 4.6 | 3,100 | 6.1 | 3,200 | 5.2 | 2,200 | 3.2 | 107.50 | |
Full year | 37,500 | 3.4 | 6,400 | 3.4 | 6,600 | 0.6 | 4,500 | (34.7) | 220.00 |
Note: Revisions to the financial result forecast most recently announced: None
* Notes(1) Significant changes in the scope of consolidation during the period: | Yes | ||||
Newly included: | 1 | company ( | Visnex Chemicals Corporation | ) | |
Excluded: | - | companies ( | ) | ||
(2) Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: | None |
(3) Changes in accounting policies, changes in accounting estimates, and restatement | |||||
(i) | Changes in accounting policies due to revisions to accounting standards and other regulations: | None | |||
(ii) | Changes in accounting policies due to other reasons: | None | |||
(iii) | Changes in accounting estimates: | None | |||
(iv) | Restatement: | None | |||
(4) Number of issued shares (common shares)
(i) Total number of issued shares at the end of the period (including treasury shares)
As of February 28, 2026 | 22,410,038 | shares |
As of November 30, 2025 | 22,410,038 | shares |
(ii) | Number of treasury shares at the end of the period | ||
As of February 28, 2026 | 2,072,767 | shares | |
As of November 30, 2025 | 2,072,767 | shares |
(iii) Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)
Three months ended February 28, 2026 | 20,337,271 | shares |
Three months ended February 28, 2025 | 20,726,729 | shares |
* Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public | |
accountants or an audit firm: | None |
* Proper use of earnings forecasts, and other special matters |
The forward-looking statements in this document, including forecasts of financial results, are based on information currently available to the Company and are subject to a number of uncertainties. Accordingly, actual results may differ from the forecasts due to changes in business conditions and other factors. Please refer to "Explanation of Consolidated Financial Results Forecast and Other Forward-looking Statements" on page 3 of the attached materials for matters related to forecasts of financial results. |
〇 Contents of Attachments
Overview of Results of Operations 2
Results of Operations for the Period under Review 2
Financial Position for the Period under Review 3
Explanation of Consolidated Financial Results Forecast and Other Forward-looking Statements 3
Quarterly Consolidated Financial Statements and Primary Notes 4
Quarterly Consolidated Balance Sheet 4
Quarterly Consolidated Statements of Income and Comprehensive Income 6
Notes to Quarterly Consolidated Financial Statements 8
Going Concern Assumption 8
Notes to Quarterly Consolidated Statements of Cash Flows 8
Changes in Scope of Consolidation or Scope of Application of Equity Method 8
Segment and Other Information 8
Significant Subsequent Events 9
-
Overview of Results of Operations
-
Results of Operations for the Period under Review
During the three months ended February 28, 2026, the Japanese economy showed a moderate recovery trend against the backdrop of the improvement in the employment and income environment, with signs of a pickup in personal consumption and capital investment. On the other hand, the outlook remains uncertain due to the continued rise in prices, trends in raw material and energy prices, the increasing geopolitical risks stemming from the escalating situation in the Middle East, as well as foreign exchange fluctuations, overseas economic conditions, and developments in trade policies in various countries.
Under these circumstances, we launched the new medium-term management plan Progress & Development 2030 (P&D 2030) covering the period from the fiscal year ended November 30, 2024 to the fiscal year ending November 30, 2030. Based on our Group management philosophy, P&D 2030 has set a management vision of "providing value to the global market as a leading company in specialty acrylic acid esters." Under this vision, we will promote sustainable management that takes ESG into account, aiming to increase corporate value and achieve sustainable growth.
In the Chemical Products Business, we worked to improve profit ratios mainly by integrating and closing products and improving production efficiency, and proceeded with expanding sales of environmentally friendly products, such as those derived from biomass. In the Electronic Materials Business, the Group worked to accelerate the development of cutting-edge semiconductor materials and to develop new applications for photoresist materials. In the Specialty Chemicals Business, the Group focused on strengthening the overseas expansion of cosmetic raw materials and expanding sales of high-purity special solvents. Following OSAKA ORGANIC CHEMICAL INDUSTRY KOREA LTD. established in 2024, we established Visnex Chemicals Corporation in North America in 2025, and we are working to strengthen our overseas sales system by acquiring new customers and cultivating new markets. In addition, in anticipation of future growth in the semiconductor market, we are planning capital investment in new facilities for cutting-edge semiconductor materials at the Sakata Plant, and it is scheduled to be completed in 2028 in order to strengthen future production capacity and supply systems.
As a result, for the three months ended February 28, 2026, the Group recorded net sales of 9,072 million yen (up 6.5% year on year), operating profit of 1,832 million yen (up 34.2% year on year), ordinary profit of 1,904 million yen (up 28.6% year on year), and profit attributable to owners of parent of 1,285 million yen (up 24.2% year on year).
Business results by segment are explained below (excluding inter-segment transactions).
Chemical Products Business
In the Chemical Products Business, sales of automotive coatings, display adhesives, and UV inkjet inks all decreased in the acrylic acid ester group. Sales in the methacrylate ester group also remained weak. As a result, net sales were 2,807 million yen (down 15.4% year on year) and segment profit was 418 million yen (down 20.6% year on year).
Electronic Materials Business
In the Electronic Materials Business, in the semiconductor materials group, sales of raw materials for ArF resists, which are the Company's mainstay, remained strong, and sales of raw materials for cutting-edge EUV resists increased significantly. On the other hand, sales in the display materials group remained weak. In addition, sales of other groups remained strong. As a result, net sales were 4,552 million yen (up 22.2% year on year) and segment profit was 983 million yen (up 85.6% year on year).
Specialty Chemicals Business
In the Specialty Chemicals Business, sales in the cosmetics materials group were flat. Sales in the functional materials group increased significantly. In addition, sales of high-purity specialty solvents at subsidiaries remained strong. As a result, net sales were 1,713 million yen (up 16.1% year on year) and segment profit was 440 million yen (up 39.8% year on year).
-
Financial Position for the Period under Review
Total assets at the end of the first quarter of the current fiscal year increased by 1,738 million yen from the end of the previous fiscal year to 65,452 million yen. This was mainly attributable to a decrease of 704 million yen in cash and deposits and an increase of 2,570 million yen in investment securities due to the rise in stock prices, etc. of shares held. Liabilities at the end of the first quarter of the current fiscal year decreased by 640 million yen from the end of the previous fiscal year to 12,536 million yen. This was mainly due to an increase of 442 million yen in accounts payable
- trade, a decrease of 369 million yen in accounts payable - other, a decrease of 1,587 million yen in income taxes payable, and an increase of 873 million yen in deferred tax liabilities.
Net assets at the end of the first quarter of the current fiscal year increased by 2,379 million yen from the end of the previous fiscal year to 52,916 million yen. This was mainly due to an increase of 472 million yen in retained earnings and an increase of 1,745 million yen in valuation difference on available-for-sale securities.
- Explanation of Consolidated Financial Results Forecast and Other Forward-looking Statements
The consolidated financial results forecast announced on January 8, 2026 remain unchanged.
-
Results of Operations for the Period under Review
- Quarterly Consolidated Financial Statements and Primary Notes
-
Quarterly Consolidated Balance Sheet
(Thousands of yen)
As of November 30, 2025
As of February 28, 2026
Assets
Current assets
Cash and deposits
15,922,597
15,218,165
Accounts receivable - trade, and contract assets
11,579,782
11,250,181
Electronically recorded monetary claims -operating
449,027
464,238
Finished goods
4,711,762
5,149,941
Work in process
2,119,445
2,323,731
Raw materials and supplies
2,326,098
2,520,492
Other
717,767
726,084
Allowance for doubtful accounts
(20,403)
(20,363)
Total current assets
37,806,078
37,632,472
Non-current assets
Property, plant and equipment
Buildings and structures, net
7,846,424
7,735,992
Machinery, equipment and vehicles, net
6,042,474
5,785,603
Land
2,172,476
2,172,476
Construction in progress
325,787
310,929
Other, net
441,508
458,398
Total property, plant and equipment
16,828,670
16,463,399
Intangible assets
Goodwill
3,333
-
Other
35,837
35,484
Total intangible assets
39,170
35,484
Investments and other assets
Investment securities
7,544,551
10,114,984
Shares of subsidiaries and associates
298,567
-
Retirement benefit asset
1,058,963
1,068,763
Deferred tax assets
3,297
3,391
Other
134,426
133,940
Total investments and other assets
9,039,805
11,321,079
Total non-current assets
25,907,647
27,819,963
Total assets
63,713,725
65,452,436
(Thousands of yen)
As of November 30, 2025
As of February 28, 2026
Liabilities
Current liabilities
Accounts payable - trade
5,775,037
6,217,130
Current portion of long-term borrowings
534,082
509,132
Accounts payable - other
1,914,021
1,544,515
Income taxes payable
2,117,602
530,258
Provision for bonuses
-
281,018
Provision for bonuses for directors (and other
officers)
63,970
9,713
Other
813,791
711,974
Total current liabilities
11,218,505
9,803,743
Non-current liabilities
Long-term borrowings
803,841
691,327
Deferred tax liabilities
1,014,083
1,887,962
Provision for share awards for directors (and other officers)
26,780
42,704
Retirement benefit liability
499
507
Other
113,513
110,004
Total non-current liabilities
1,958,717
2,732,506
Total liabilities
13,177,222
12,536,250
Net assets
Shareholders' equity
Share capital
3,600,295
3,600,295
Capital surplus
3,513,349
3,513,349
Retained earnings
44,177,940
44,650,144
Treasury shares
(5,326,546)
(5,326,546)
Total shareholders' equity
45,965,038
46,437,242
Accumulated other comprehensive income
Valuation difference on available-for-sale
securities
3,140,180
4,885,595
Foreign currency translation adjustment
186,810
220,951
Remeasurements of defined benefit plans
408,689
403,150
Total accumulated other comprehensive income
3,735,680
5,509,697
Non-controlling interests
835,783
969,246
Total net assets
50,536,502
52,916,186
Total liabilities and net assets
63,713,725
65,452,436
-
Quarterly Consolidated Statements of Income and Comprehensive Income
Quarterly Consolidated Statement of Income For the Three-Month Period
(Thousands of yen)
For the three months ended February 28, 2025
For the three months ended February 28, 2026
Net sales
8,516,926
9,072,876
Cost of sales
5,846,560
5,947,511
Gross profit
2,670,366
3,125,364
Selling, general and administrative expenses
1,304,495
1,292,384
Operating profit
1,365,870
1,832,979
Non-operating income
Interest income
2,771
1,747
Dividend income
36,842
39,550
Foreign exchange gains
-
6,215
Insurance claim income
97,183
-
Other
28,683
25,971
Total non-operating income
165,480
73,484
Non-operating expenses
Interest expenses
2,406
1,153
Foreign exchange losses
45,193
-
Commission for purchase of treasury shares
2,400
-
Loss on investments in investment partnerships
506
904
Other
0
95
Total non-operating expenses
50,507
2,153
Ordinary profit
1,480,843
1,904,310
Extraordinary losses
Loss on retirement of non-current assets
199
2,926
Total extraordinary losses
199
2,926
Profit before income taxes
1,480,644
1,901,383
Income taxes - current
466,937
510,839
Income taxes - deferred
(68,048)
63,092
Total income taxes
398,888
573,931
Profit
1,081,755
1,327,451
Profit attributable to non-controlling interests
46,306
41,757
Profit attributable to owners of parent
1,035,449
1,285,694
Quarterly Consolidated Statement of Comprehensive Income For the Three-Month Period
(Thousands of yen)
For the three months ended February 28, 2025
For the three months ended February 28, 2026
Profit
1,081,755
1,327,451
Other comprehensive income
Valuation difference on available-for-sale securities
(211,286)
1,758,033
Foreign currency translation adjustment
(32,776)
34,730
Remeasurements of defined benefit plans, net of tax
(2,559)
(5,678)
Total other comprehensive income
(246,623)
1,787,085
Comprehensive income
835,132
3,114,537
Comprehensive income attributable to
Comprehensive income attributable to owners of
parent
788,214
3,059,712
Comprehensive income attributable to non-controlling interests
46,917
54,825
-
Notes to Quarterly Consolidated Financial Statements Going Concern Assumption
Not applicable.
Notes to Quarterly Consolidated Statements of Cash FlowsThe quarterly consolidated statements of cash flows for the three months ended February 28, 2026 have not been prepared.
Depreciation related to the three months ended February 28, 2026 (including amortization related to intangible assets excluding goodwill) and amortization of goodwill are as follows.
(Thousands of yen)
Changes in Scope of Consolidation or Scope of Application of Equity MethodFor the three months ended February 28, 2025
(Dec. 1, 2024 - Feb. 28, 2025)
For the three months ended February 28, 2026
(Dec. 1, 2025 - Feb. 28, 2026)
Depreciation
721,502
657,589
Amortization of goodwill
4,999
3,333
(Significant Change in the Scope of Consolidation)
Visnex Chemicals Corporation, which was a non-consolidated subsidiary in the previous fiscal year, is included in the scope of consolidation from the first quarter of the current fiscal year due to its increased importance.
Segment and Other Information[Segment Information]
For the three months ended February 28, 2025 (Dec. 1, 2024 - Feb. 28, 2025)
Information on the amounts of sales, profits or losses by reportable segment and information on disaggregation of revenue
(Thousands of yen)
Reportable segment
Adjustment (Note 1)
Amounts shown on quarterly consolidated statement of income
(Note 2)
Chemical Products Business
Electronic Materials Business
Specialty Chemicals Business
Total
Net sales
Japan
1,586,393
3,154,050
1,113,708
5,854,152
-
5,854,152
Asia and Australia
1,215,493
563,431
307,617
2,086,542
-
2,086,542
Americas
359,255
6,614
54,785
420,654
-
420,654
Europe
155,006
570
-
155,576
-
155,576
Revenue from contracts with
customers
3,316,149
3,724,665
1,476,110
8,516,926
-
8,516,926
Other revenues
-
-
-
-
-
-
Sales to external customers
3,316,149
3,724,665
1,476,110
8,516,926
-
8,516,926
Inter-segment sales and
transfers
-
-
118,196
118,196
(118,196)
-
Total
3,316,149
3,724,665
1,594,307
8,635,123
(118,196)
8,516,926
Segment profit
527,628
530,126
315,210
1,372,965
(7,094)
1,365,870
(Notes) 1. Segment profit in the above adjustment represents eliminations for inter-segment transactions.
Segment profit is adjusted to be consistent with the operating profit on the quarterly consolidated statement of income.
2. Information related to impairment losses on non-current assets or goodwill, etc. for each reportable segment Not applicable.
For the three months ended February 28, 2026 (Dec. 1, 2025 - Feb. 28, 2026)
Information on the amounts of sales, profits or losses by reportable segment and information on disaggregation of revenue
(Thousands of yen)
Reportable segment
Adjustment (Note 1)
Amounts shown on quarterly consolidated statement of income
(Note 2)
Chemical Products Business
Electronic Materials Business
Specialty Chemicals Business
Total
Net sales
Japan
1,476,316
3,930,482
1,361,695
6,768,494
-
6,768,494
Asia and Australia
1,148,941
619,314
313,567
2,081,822
-
2,081,822
Americas
62,177
2,878
22,951
88,006
-
88,006
Europe
119,599
-
14,952
134,551
-
134,551
Revenue from contracts with
customers
2,807,034
4,552,674
1,713,166
9,072,876
-
9,072,876
Other revenues
-
-
-
-
-
-
Sales to external customers
2,807,034
4,552,674
1,713,166
9,072,876
-
9,072,876
Inter-segment sales and
transfers
-
-
147,573
147,573
(147,573)
-
Total
2,807,034
4,552,674
1,860,739
9,220,449
(147,573)
9,072,876
Segment profit
418,702
983,952
440,817
1,843,472
(10,492)
1,832,979
(Notes) 1. Segment profit in the above adjustment represents eliminations for inter-segment transactions.
Segment profit is adjusted to be consistent with the operating profit on the quarterly consolidated statement of income.
2. Information related to impairment losses on non-current assets or goodwill, etc. for each reportable segment Not applicable.
Significant Subsequent EventsNot applicable.
